Ryan D Gabbard Selected Research

Complementation Group B Xeroderma Pigmentosum

1/2020

Spironolactone and XPB: An Old Drug with a New Molecular Target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryan D Gabbard Research Topics

Disease

1	Liver Failure 06/2022
1	Disseminated Intravascular Coagulation 06/2022
1	Hemorrhage 06/2022
1	Granuloma 12/2021
1	Foreign Bodies (Foreign Body) 12/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Complementation Group B Xeroderma Pigmentosum 01/2020
1	Acne Vulgaris 01/2020
1	Alopecia (Baldness) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Heart Failure 01/2020
1	Hirsutism 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Neoplasms (Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

1	Dacarbazine (DIC)FDA LinkGeneric 06/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 12/2021
1	Dermal FillersIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2020
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020

Therapy/Procedure

1	Subcutaneous Injections 12/2021